Novartis inks $1.7 Billion skin-disease pact with AI startup Relation
Novartis and Relation Therapeutics have struck a $1.7 billion collaboration to discover new immuno-dermatology drug targets using Relation’s AI-powered “Lab-in-the-Loop” platform.